Rapid Wuchereria bancrofti-specific antigen Wb123-based IgG4 immunoassays as tools for surveillance following mass drug administration programs on lymphatic filariasis.
Identifieur interne : 001924 ( PubMed/Checkpoint ); précédent : 001923; suivant : 001925Rapid Wuchereria bancrofti-specific antigen Wb123-based IgG4 immunoassays as tools for surveillance following mass drug administration programs on lymphatic filariasis.
Auteurs : Cathy Steel [États-Unis] ; Allison Golden ; Joseph Kubofcik ; Nicole Larue ; Tala De Los Santos ; Gonzalo J. Domingo ; Thomas B. NutmanSource :
- Clinical and vaccine immunology : CVI [ 1556-679X ] ; 2013.
Descripteurs français
- KwdFr :
- Animaux, Anticorps antihelminthe (sang), Antigènes d'helminthe, Antihelminthiques (usage thérapeutique), Filariose lymphatique (diagnostic), Filariose lymphatique (traitement médicamenteux), Humains, Immunochromatographie (), Immunoglobuline G (sang), Sensibilité et spécificité, Surveillance pharmacologique (), Techniques de laboratoire clinique (), Test ELISA (), Valeur prédictive des tests, Wuchereria bancrofti (immunologie).
- MESH :
- diagnostic : Filariose lymphatique.
- immunologie : Wuchereria bancrofti.
- sang : Anticorps antihelminthe, Immunoglobuline G.
- traitement médicamenteux : Filariose lymphatique.
- usage thérapeutique : Antihelminthiques.
- Animaux, Antigènes d'helminthe, Humains, Immunochromatographie, Sensibilité et spécificité, Surveillance pharmacologique, Techniques de laboratoire clinique, Test ELISA, Valeur prédictive des tests.
English descriptors
- KwdEn :
- Animals, Anthelmintics (therapeutic use), Antibodies, Helminth (blood), Antigens, Helminth, Clinical Laboratory Techniques (methods), Drug Monitoring (methods), Elephantiasis, Filarial (diagnosis), Elephantiasis, Filarial (drug therapy), Enzyme-Linked Immunosorbent Assay (methods), Humans, Immunochromatography (methods), Immunoglobulin G (blood), Predictive Value of Tests, Sensitivity and Specificity, Wuchereria bancrofti (immunology).
- MESH :
- chemical , blood : Antibodies, Helminth, Immunoglobulin G.
- chemical , therapeutic use : Anthelmintics.
- diagnosis : Elephantiasis, Filarial.
- drug therapy : Elephantiasis, Filarial.
- immunology : Wuchereria bancrofti.
- methods : Clinical Laboratory Techniques, Drug Monitoring, Enzyme-Linked Immunosorbent Assay, Immunochromatography.
- Animals, Antigens, Helminth, Humans, Predictive Value of Tests, Sensitivity and Specificity.
Abstract
The Global Programme to Eliminate Lymphatic Filariasis has an urgent need for rapid assays to detect ongoing transmission of lymphatic filariasis (LF) following multiple rounds of mass drug administration (MDA). Current WHO guidelines support using the antigen card immunochromatographic test (ICT), which detects active filarial infection but does not detect early exposure to LF. Recent studies found that antibody-based assays better serve this function. In the present study, two tests, a rapid IgG4 enzyme-linked immunosorbent assay (ELISA) and a lateral-flow strip immunoassay, were developed based on the highly sensitive and specific Wuchereria bancrofti antigen Wb123. A comparison of W. bancrofti-infected and -uninfected patients (with or without other helminth infections) demonstrated that both tests had high sensitivities and specificities (93 and 97% [ELISA] and 92 and 96% [strips], respectively). When the W. bancrofti-uninfected group was separated into those with other filarial/helminth infections (i.e., onchocerciasis, loiasis, and strongyloidiasis) and those who were parasite uninfected, the specificities of the assays varied between 91 and 100%. In addition, the geometric mean response by ELISA of W. bancrofti-infected patients was significantly higher than the response of those without W. bancrofti infection (P < 0.0001). Furthermore, the Wb123 ELISA and the lateral-flow strips had high positive and negative predictive values, giving valuable information on the size of survey population needed to be reasonably certain whether or not transmission is ongoing. These highly sensitive and specific IgG4 tests to the W. bancrofti Wb123 protein give every indication that they will serve as useful tools for post-MDA monitoring.
DOI: 10.1128/CVI.00252-13
PubMed: 23740923
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:23740923Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Rapid Wuchereria bancrofti-specific antigen Wb123-based IgG4 immunoassays as tools for surveillance following mass drug administration programs on lymphatic filariasis.</title><author><name sortKey="Steel, Cathy" sort="Steel, Cathy" uniqKey="Steel C" first="Cathy" last="Steel">Cathy Steel</name><affiliation wicri:level="2"><nlm:affiliation>Laboratory of Parasitic Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Laboratory of Parasitic Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Golden, Allison" sort="Golden, Allison" uniqKey="Golden A" first="Allison" last="Golden">Allison Golden</name></author><author><name sortKey="Kubofcik, Joseph" sort="Kubofcik, Joseph" uniqKey="Kubofcik J" first="Joseph" last="Kubofcik">Joseph Kubofcik</name></author><author><name sortKey="Larue, Nicole" sort="Larue, Nicole" uniqKey="Larue N" first="Nicole" last="Larue">Nicole Larue</name></author><author><name sortKey="De Los Santos, Tala" sort="De Los Santos, Tala" uniqKey="De Los Santos T" first="Tala" last="De Los Santos">Tala De Los Santos</name></author><author><name sortKey="Domingo, Gonzalo J" sort="Domingo, Gonzalo J" uniqKey="Domingo G" first="Gonzalo J" last="Domingo">Gonzalo J. Domingo</name></author><author><name sortKey="Nutman, Thomas B" sort="Nutman, Thomas B" uniqKey="Nutman T" first="Thomas B" last="Nutman">Thomas B. Nutman</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23740923</idno><idno type="pmid">23740923</idno><idno type="doi">10.1128/CVI.00252-13</idno><idno type="wicri:Area/PubMed/Corpus">001A98</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001A98</idno><idno type="wicri:Area/PubMed/Curation">001A98</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001A98</idno><idno type="wicri:Area/PubMed/Checkpoint">001A98</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001A98</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Rapid Wuchereria bancrofti-specific antigen Wb123-based IgG4 immunoassays as tools for surveillance following mass drug administration programs on lymphatic filariasis.</title><author><name sortKey="Steel, Cathy" sort="Steel, Cathy" uniqKey="Steel C" first="Cathy" last="Steel">Cathy Steel</name><affiliation wicri:level="2"><nlm:affiliation>Laboratory of Parasitic Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Laboratory of Parasitic Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Golden, Allison" sort="Golden, Allison" uniqKey="Golden A" first="Allison" last="Golden">Allison Golden</name></author><author><name sortKey="Kubofcik, Joseph" sort="Kubofcik, Joseph" uniqKey="Kubofcik J" first="Joseph" last="Kubofcik">Joseph Kubofcik</name></author><author><name sortKey="Larue, Nicole" sort="Larue, Nicole" uniqKey="Larue N" first="Nicole" last="Larue">Nicole Larue</name></author><author><name sortKey="De Los Santos, Tala" sort="De Los Santos, Tala" uniqKey="De Los Santos T" first="Tala" last="De Los Santos">Tala De Los Santos</name></author><author><name sortKey="Domingo, Gonzalo J" sort="Domingo, Gonzalo J" uniqKey="Domingo G" first="Gonzalo J" last="Domingo">Gonzalo J. Domingo</name></author><author><name sortKey="Nutman, Thomas B" sort="Nutman, Thomas B" uniqKey="Nutman T" first="Thomas B" last="Nutman">Thomas B. Nutman</name></author></analytic><series><title level="j">Clinical and vaccine immunology : CVI</title><idno type="eISSN">1556-679X</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Anthelmintics (therapeutic use)</term><term>Antibodies, Helminth (blood)</term><term>Antigens, Helminth</term><term>Clinical Laboratory Techniques (methods)</term><term>Drug Monitoring (methods)</term><term>Elephantiasis, Filarial (diagnosis)</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Enzyme-Linked Immunosorbent Assay (methods)</term><term>Humans</term><term>Immunochromatography (methods)</term><term>Immunoglobulin G (blood)</term><term>Predictive Value of Tests</term><term>Sensitivity and Specificity</term><term>Wuchereria bancrofti (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Anticorps antihelminthe (sang)</term><term>Antigènes d'helminthe</term><term>Antihelminthiques (usage thérapeutique)</term><term>Filariose lymphatique (diagnostic)</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Humains</term><term>Immunochromatographie ()</term><term>Immunoglobuline G (sang)</term><term>Sensibilité et spécificité</term><term>Surveillance pharmacologique ()</term><term>Techniques de laboratoire clinique ()</term><term>Test ELISA ()</term><term>Valeur prédictive des tests</term><term>Wuchereria bancrofti (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Helminth</term><term>Immunoglobulin G</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anthelmintics</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Clinical Laboratory Techniques</term><term>Drug Monitoring</term><term>Enzyme-Linked Immunosorbent Assay</term><term>Immunochromatography</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antihelminthe</term><term>Immunoglobuline G</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antihelminthiques</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Antigens, Helminth</term><term>Humans</term><term>Predictive Value of Tests</term><term>Sensitivity and Specificity</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Antigènes d'helminthe</term><term>Humains</term><term>Immunochromatographie</term><term>Sensibilité et spécificité</term><term>Surveillance pharmacologique</term><term>Techniques de laboratoire clinique</term><term>Test ELISA</term><term>Valeur prédictive des tests</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The Global Programme to Eliminate Lymphatic Filariasis has an urgent need for rapid assays to detect ongoing transmission of lymphatic filariasis (LF) following multiple rounds of mass drug administration (MDA). Current WHO guidelines support using the antigen card immunochromatographic test (ICT), which detects active filarial infection but does not detect early exposure to LF. Recent studies found that antibody-based assays better serve this function. In the present study, two tests, a rapid IgG4 enzyme-linked immunosorbent assay (ELISA) and a lateral-flow strip immunoassay, were developed based on the highly sensitive and specific Wuchereria bancrofti antigen Wb123. A comparison of W. bancrofti-infected and -uninfected patients (with or without other helminth infections) demonstrated that both tests had high sensitivities and specificities (93 and 97% [ELISA] and 92 and 96% [strips], respectively). When the W. bancrofti-uninfected group was separated into those with other filarial/helminth infections (i.e., onchocerciasis, loiasis, and strongyloidiasis) and those who were parasite uninfected, the specificities of the assays varied between 91 and 100%. In addition, the geometric mean response by ELISA of W. bancrofti-infected patients was significantly higher than the response of those without W. bancrofti infection (P < 0.0001). Furthermore, the Wb123 ELISA and the lateral-flow strips had high positive and negative predictive values, giving valuable information on the size of survey population needed to be reasonably certain whether or not transmission is ongoing. These highly sensitive and specific IgG4 tests to the W. bancrofti Wb123 protein give every indication that they will serve as useful tools for post-MDA monitoring.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23740923</PMID><DateCreated><Year>2013</Year><Month>07</Month><Day>29</Day></DateCreated><DateCompleted><Year>2014</Year><Month>02</Month><Day>13</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1556-679X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>8</Issue><PubDate><Year>2013</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Clinical and vaccine immunology : CVI</Title><ISOAbbreviation>Clin. Vaccine Immunol.</ISOAbbreviation></Journal><ArticleTitle>Rapid Wuchereria bancrofti-specific antigen Wb123-based IgG4 immunoassays as tools for surveillance following mass drug administration programs on lymphatic filariasis.</ArticleTitle><Pagination><MedlinePgn>1155-61</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/CVI.00252-13</ELocationID><Abstract><AbstractText>The Global Programme to Eliminate Lymphatic Filariasis has an urgent need for rapid assays to detect ongoing transmission of lymphatic filariasis (LF) following multiple rounds of mass drug administration (MDA). Current WHO guidelines support using the antigen card immunochromatographic test (ICT), which detects active filarial infection but does not detect early exposure to LF. Recent studies found that antibody-based assays better serve this function. In the present study, two tests, a rapid IgG4 enzyme-linked immunosorbent assay (ELISA) and a lateral-flow strip immunoassay, were developed based on the highly sensitive and specific Wuchereria bancrofti antigen Wb123. A comparison of W. bancrofti-infected and -uninfected patients (with or without other helminth infections) demonstrated that both tests had high sensitivities and specificities (93 and 97% [ELISA] and 92 and 96% [strips], respectively). When the W. bancrofti-uninfected group was separated into those with other filarial/helminth infections (i.e., onchocerciasis, loiasis, and strongyloidiasis) and those who were parasite uninfected, the specificities of the assays varied between 91 and 100%. In addition, the geometric mean response by ELISA of W. bancrofti-infected patients was significantly higher than the response of those without W. bancrofti infection (P < 0.0001). Furthermore, the Wb123 ELISA and the lateral-flow strips had high positive and negative predictive values, giving valuable information on the size of survey population needed to be reasonably certain whether or not transmission is ongoing. These highly sensitive and specific IgG4 tests to the W. bancrofti Wb123 protein give every indication that they will serve as useful tools for post-MDA monitoring.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Steel</LastName><ForeName>Cathy</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Parasitic Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golden</LastName><ForeName>Allison</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Kubofcik</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>LaRue</LastName><ForeName>Nicole</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>de Los Santos</LastName><ForeName>Tala</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Domingo</LastName><ForeName>Gonzalo J</ForeName><Initials>GJ</Initials></Author><Author ValidYN="Y"><LastName>Nutman</LastName><ForeName>Thomas B</ForeName><Initials>TB</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D023362">Evaluation Studies</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>06</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Vaccine Immunol</MedlineTA><NlmUniqueID>101252125</NlmUniqueID><ISSNLinking>1556-679X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000871">Anthelmintics</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000909">Antibodies, Helminth</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000947">Antigens, Helminth</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2001 Nov;65(5):498-503</RefSource><PMID Version="1">11716104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 2012 Sep 14;87(37):346-56</RefSource><PMID Version="1">22977953</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 1988 Nov;158(5):1034-7</RefSource><PMID Version="1">2460565</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2006 Jul;100(7):656-62</RefSource><PMID Version="1">16414095</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2012;6(12):e1930</RefSource><PMID Version="1">23236529</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2012;6(12):e1941</RefSource><PMID Version="1">23236534</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2012;6(12):e1940</RefSource><PMID Version="1">23236533</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diagn Microbiol Infect Dis. 2010 Dec;68(4):410-5</RefSource><PMID Version="1">21094425</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Filaria J. 2004 Sep 3;3(1):9</RefSource><PMID Version="1">15347425</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Vaccine Immunol. 2006 Dec;13(12):1307-13</RefSource><PMID Version="1">17035513</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbiol Immunol. 2009 Mar;53(3):173-83</RefSource><PMID Version="1">19302528</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Filaria J. 2007 Oct 26;6:10</RefSource><PMID Version="1">17961264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2011 Aug;85(2):229-37</RefSource><PMID Version="1">21813840</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2006 Mar 25;367(9515):992-9</RefSource><PMID Version="1">16564361</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2008;2(12):e344</RefSource><PMID Version="1">19065257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Trop. 2011 Sep;120 Suppl 1:S19-22</RefSource><PMID Version="1">20430004</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000871" MajorTopicYN="N">Anthelmintics</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000909" MajorTopicYN="N">Antibodies, Helminth</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000947" MajorTopicYN="Y">Antigens, Helminth</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019411" MajorTopicYN="N">Clinical Laboratory Techniques</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016903" MajorTopicYN="N">Drug Monitoring</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059665" MajorTopicYN="N">Immunochromatography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014958" MajorTopicYN="N">Wuchereria bancrofti</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC3754496</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23740923</ArticleId><ArticleId IdType="pii">CVI.00252-13</ArticleId><ArticleId IdType="doi">10.1128/CVI.00252-13</ArticleId><ArticleId IdType="pmc">PMC3754496</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Maryland</li></region></list><tree><noCountry><name sortKey="De Los Santos, Tala" sort="De Los Santos, Tala" uniqKey="De Los Santos T" first="Tala" last="De Los Santos">Tala De Los Santos</name><name sortKey="Domingo, Gonzalo J" sort="Domingo, Gonzalo J" uniqKey="Domingo G" first="Gonzalo J" last="Domingo">Gonzalo J. Domingo</name><name sortKey="Golden, Allison" sort="Golden, Allison" uniqKey="Golden A" first="Allison" last="Golden">Allison Golden</name><name sortKey="Kubofcik, Joseph" sort="Kubofcik, Joseph" uniqKey="Kubofcik J" first="Joseph" last="Kubofcik">Joseph Kubofcik</name><name sortKey="Larue, Nicole" sort="Larue, Nicole" uniqKey="Larue N" first="Nicole" last="Larue">Nicole Larue</name><name sortKey="Nutman, Thomas B" sort="Nutman, Thomas B" uniqKey="Nutman T" first="Thomas B" last="Nutman">Thomas B. Nutman</name></noCountry><country name="États-Unis"><region name="Maryland"><name sortKey="Steel, Cathy" sort="Steel, Cathy" uniqKey="Steel C" first="Cathy" last="Steel">Cathy Steel</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001924 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001924 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:23740923
|texte= Rapid Wuchereria bancrofti-specific antigen Wb123-based IgG4 immunoassays as tools for surveillance following mass drug administration programs on lymphatic filariasis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:23740923" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |